Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

NCT07238400 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07238400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
March 20, 2026
Completion date
March 30, 2029
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension